January 5th 2022
Adam M. Brufsky, MD, PhD, FACP, discusses efficacy data with enobosarm in metastatic estrogen receptor–positive, androgen receptor–positive, HER2-negative breast cancer.
February 16th 2021
February 9th 2021
February 2nd 2021
January 26th 2021
January 19th 2021